海爾智家(600690.SH)發行H股及H股可轉債申請獲中證監受理
格隆匯9月10日丨海爾智家(600690.SH)宣佈,公司於近日向中國證監會提交了關於發行境外上市外資股(H股)並以介紹方式在香港聯交所主板掛牌上市及發行可轉換為境外上市外資股(H股)的公司債券(即EB轉CB方案)的申請材料。2020年9月10日,公司收到中國證監會出具的《中國證監會行政許可申請受理單》(受理序號:202398)。
公司該次發行H股及H股可轉債以公司私有化海爾電器(01169.HK)方案生效為先決條件,尚需取得中國證監會、香港聯交所、百慕大最高法院等相關政府機構、監管部門的核準、同意和/或備案,以及海爾電器股東大會、百慕大最高法院會議審議通過等條件的達成,該等事項存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.